pheochromocytoma
PHEOCHROMOCYTOMA
Pheochromocytoma is a rare adrenal gland tumor that may precipitate life-threatening hypertension.
It can occur at any age but usually occurs during young to mid-adult life.
Majority of patients presents with ≥1 of the following hypertension resistant to standard antihypertensive treatment, hypertensive crisis with malignant hypertension, hypertensive encephalopathy, aortic dissection, or myocardial infarction and paroxysmal symptoms which suggest seizure disorder, anxiety attacks or hyperventilation.

Pheochromocytoma Treatment

Pharmacotherapy

Alpha-Adrenergic Blockade

  • First-line therapy used to minimize complications prior to surgery

Phenoxybenzamine

  • Action: Powerful irreversible alpha-adrenergic blocker of the alpha receptors in the smooth muscles
  • Effects: Oral administration results in an onset of action w/in a few hr & persists for up to 3-4 days
    • Used to control the hypertension caused by excessive catecholamine release by pheochromocytoma

Selective Alpha1-Antagonists

  • Eg Doxazosin
  • Action: Selective blockade of alpha1-adrenoreceptors
  • Effects: Limited use in pheochromocytoma, Phenoxybenzamine is more effective
  • May be used to treat individual paroxysms
  • May also may be used to treat hypertension while pheochromocytoma workup is ongoing
    • Better tolerated than Phenoxybenzamine
    • Prevent serious pressor crisis if pheochromocytoma is present

Beta-Blockers

  • Eg Propranolol, Atenolol
  • Administer only after alpha blockade has been induced
    • W/o alpha blockade paradox increase in BP may occur
  • Action: Competitive antagonists of catecholamines at beta-adrenergic receptors
  • Effects: Used to treat tachycardia that may develop w/ alpha blockade
    • Assist in preventing catecholamine-induced arrhythmias
  • Low doses are usually sufficient

Calcium Channel Blockers

  • Eg Nifedipine, Amlodipine
  • Used as add-on treatment to alpha-adrenergic receptor blockers to further improve cardiovascular function peri-operatively
  • Action: Blocks slow calcium channels to prevent calcium ion flow into the cell
  • Effects: Vasodilatation, reduced afterload, peripheral resistance & blood pressure

Metirosine (Metyrosine)

  • Action: Inhibits tyrosine hydroxylase which inhibits synthesis of catecholamines by the tumor
  • Effects: Simplifies chronic management
  • Should be used if other agents are ineffective or when tumor destruction will be marked
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Roshini Claire Anthony, 24 Feb 2021

Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) did not result in worsening renal function or bone mineral density (BMD) in Asian patients with chronic hepatitis B virus (HBV) infection, according to a small real-world prospective study.

Roshini Claire Anthony, 6 days ago

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.

Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.